Skip to main content

Table 1 Cardiac FDG-PET parameters

From: Cardioprotective effects of adenosine within the border and remote areas of myocardial infarction

 

Control (n = 7)

CADO (n = 8)

8-SPT (n = 8)

48 h

   

 Extent of MI area (% of LV)

35 ± 6

32 ± 15

32 ± 21

 EDV (μL)

412 ± 61

397 ± 57

441 ± 66

 ESV (μL)

239 ± 48

230 ± 43

257 ± 74

 EF (%)

42 ± 7

42 ± 6

42 ± 7

1 month

   

 Extent of MI area (% of LV)

32 ± 9

29 ± 14

33 ± 23

  Change from 48 h

−3 ± 7

−3 ± 4

1 ± 7

 EDV (μL)

600 ± 95

576 ± 111

666 ± 175

  Change from 48 h

188 ± 76

179 ± 120

225 ± 160

 ESV (μL)

353 ± 67

324 ± 106

428 ± 185

  Change from 48 h

114 ± 61

94 ± 112

171 ± 149

 EF (%)

42 ± 2

45 ± 9

38 ± 12

  Change from 48 h

0 ± 8

3 ± 10

−5 ± 7

2 months

   

 Extent of MI area (% of LV)

30 ± 11

26 ± 15

32 ± 27

  Change from 48 h

−5 ± 9

−7 ± 8

0 ± 9

 EDV (μL)

692 ± 132

637 ± 151

780 ± 232

  Change from 48 h

280 ± 113

241 ± 158

339 ± 212

 ESV (μL)

432 ± 120

379 ± 149

530 ± 210

  Change from 48 h

19 ± 99

149 ± 145

273 ± 174

 EF (%)

38 ± 5

42 ± 8

34 ± 10

  Change from 48 h

−4 ± 6

0 ± 8

−9 ± 6